— Know what they know.
Not Investment Advice
Also trades as: COV.V (TSXV) · $vol 0M

CVALF OTC

Covalon Technologies Ltd.
1W: -10.0% 1M: +25.6% 3M: +83.7% YTD: +97.1% 1Y: +95.7% 3Y: +94.2% 5Y: +123.1%
$2.70
-0.03 (-1.10%)
 
Weekly Expected Move ±12.5%
$2 $2 $3 $3 $3
OTC · Healthcare · Medical - Instruments & Supplies · Tech Score Buy · Power 72 · $74.6M mcap · 15M float · 0.090% daily turnover · Short 64% of daily vol

Cash Flow Trends

Operating Cash Flow
$2M -52.7% ▼
Capital Expenditures
$463K -11.0% ▼
5Y CAGR: +4.5%
Free Cash Flow
$1M -61.4% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$93K -98.8% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$419K-$9M-$4M$3M$2M
Depreciation & Amort.$700K$1M$969K$986K$955K
Stock-Based Comp.$164K$211K$559K$406K$274K
Change in Working Capital-$1M-$83K-$318K-$283K-$1M
Other Non-Cash Items$419K$99K$66K-$306K-$432K
Operating Cash Flow$621K-$8M-$3M$3M$2M
— Investing Activities —
Capital Expenditures-$178K-$1M-$495K-$291K-$644K
Acquisitions (Net)$0$102K$0$0$0
Investment Purchases-$101K-$239K$0$0$0
Investment Sales$0$137K$0$0$0
Other Investing$27M$239K$414K$9K$36K
Investing Cash Flow-$279K-$843K-$81K-$282K-$608K
— Financing Activities —
Net Debt Issuance-$8M-$585K-$684K-$485K-$573K
Stock Repurchased$0-$2M-$1M$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$286K$126K$0$5M$162K
Financing Cash Flow-$8M-$2M-$2M$5M-$380K
Net Change in Cash$19M-$9M-$5M$8M$93K
Cash End of Period$23M$14M$9M$17M$12M
Free Cash Flow$444K-$9M-$5M$3M$1M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms